Evaluation of the willingness-to-pay for cancer treatment in Korean metastatic breast cancer patients

A multicenter, cross-sectional study

Do Youn Oh, Bruce Crawford, Sung Bae Kim, Hyuncheol Chung, Jeffrey Mcdonald, Sang Yoon Lee, Su Kyoung Ko, Jungsil Ro

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Aims: To evaluate the inherent value of breast cancer therapy a willingness-to-pay (WTP) study was conducted in Korean patients with metastatic breast cancer. Methods: Patients were prospectively enrolled from four study centers and completed quality of life questionnaires to reflect their status pre-cancer and their current health status. Clinical and socioeconomic data were collected to characterize the population and utilize during modeling. Patients' WTP for breast cancer treatment was assessed using an open-ended question following three rounds of bidding to better hone in on their maximal WTP, starting with one of three randomly assigned start bids. Predictors of patient WTP was evaluated using linear regression models. Associations between WTP and other parameters were evaluated with correlations. Results: Korean metastatic breast cancer patients were WTP an average of KRW 8696329 (US$7555) per month to return to their pre-cancer health state, with those who were recently diagnosed as WTP the most (KRW 12955000 [$11254]). WTP was closely associated with the patient's education level, income, personal financial difficulties, Eastern Cooperative Oncology Group performance status, and their experience of arm symptoms. Conclusion: The results suggest that patients are WTP significant amounts per month for treatment. Breast cancer patients are heavily burdened physically, mentally and financially, and the present study indicated this significant financial burden by disclosing its relationship with WTP. Providing a better understanding of the inherent value of treatment will allow Koreans to better evaluate treatment in the coming era of personalized medicine.

Original languageEnglish
Pages (from-to)282-291
Number of pages10
JournalAsia-Pacific Journal of Clinical Oncology
Volume8
Issue number3
DOIs
Publication statusPublished - 2012 Sep 1

Fingerprint

Cross-Sectional Studies
Breast Neoplasms
Neoplasms
Therapeutics
Linear Models
Precision Medicine
Patient Education
Health Status
Quality of Life
Health
Population

All Science Journal Classification (ASJC) codes

  • Oncology

Cite this

Oh, Do Youn ; Crawford, Bruce ; Kim, Sung Bae ; Chung, Hyuncheol ; Mcdonald, Jeffrey ; Lee, Sang Yoon ; Ko, Su Kyoung ; Ro, Jungsil. / Evaluation of the willingness-to-pay for cancer treatment in Korean metastatic breast cancer patients : A multicenter, cross-sectional study. In: Asia-Pacific Journal of Clinical Oncology. 2012 ; Vol. 8, No. 3. pp. 282-291.
@article{db54481d23764e3390abe3484985ef69,
title = "Evaluation of the willingness-to-pay for cancer treatment in Korean metastatic breast cancer patients: A multicenter, cross-sectional study",
abstract = "Aims: To evaluate the inherent value of breast cancer therapy a willingness-to-pay (WTP) study was conducted in Korean patients with metastatic breast cancer. Methods: Patients were prospectively enrolled from four study centers and completed quality of life questionnaires to reflect their status pre-cancer and their current health status. Clinical and socioeconomic data were collected to characterize the population and utilize during modeling. Patients' WTP for breast cancer treatment was assessed using an open-ended question following three rounds of bidding to better hone in on their maximal WTP, starting with one of three randomly assigned start bids. Predictors of patient WTP was evaluated using linear regression models. Associations between WTP and other parameters were evaluated with correlations. Results: Korean metastatic breast cancer patients were WTP an average of KRW 8696329 (US$7555) per month to return to their pre-cancer health state, with those who were recently diagnosed as WTP the most (KRW 12955000 [$11254]). WTP was closely associated with the patient's education level, income, personal financial difficulties, Eastern Cooperative Oncology Group performance status, and their experience of arm symptoms. Conclusion: The results suggest that patients are WTP significant amounts per month for treatment. Breast cancer patients are heavily burdened physically, mentally and financially, and the present study indicated this significant financial burden by disclosing its relationship with WTP. Providing a better understanding of the inherent value of treatment will allow Koreans to better evaluate treatment in the coming era of personalized medicine.",
author = "Oh, {Do Youn} and Bruce Crawford and Kim, {Sung Bae} and Hyuncheol Chung and Jeffrey Mcdonald and Lee, {Sang Yoon} and Ko, {Su Kyoung} and Jungsil Ro",
year = "2012",
month = "9",
day = "1",
doi = "10.1111/j.1743-7563.2012.01546.x",
language = "English",
volume = "8",
pages = "282--291",
journal = "Asia-Pacific Journal of Clinical Oncology",
issn = "1743-7555",
publisher = "Wiley-Blackwell",
number = "3",

}

Evaluation of the willingness-to-pay for cancer treatment in Korean metastatic breast cancer patients : A multicenter, cross-sectional study. / Oh, Do Youn; Crawford, Bruce; Kim, Sung Bae; Chung, Hyuncheol; Mcdonald, Jeffrey; Lee, Sang Yoon; Ko, Su Kyoung; Ro, Jungsil.

In: Asia-Pacific Journal of Clinical Oncology, Vol. 8, No. 3, 01.09.2012, p. 282-291.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Evaluation of the willingness-to-pay for cancer treatment in Korean metastatic breast cancer patients

T2 - A multicenter, cross-sectional study

AU - Oh, Do Youn

AU - Crawford, Bruce

AU - Kim, Sung Bae

AU - Chung, Hyuncheol

AU - Mcdonald, Jeffrey

AU - Lee, Sang Yoon

AU - Ko, Su Kyoung

AU - Ro, Jungsil

PY - 2012/9/1

Y1 - 2012/9/1

N2 - Aims: To evaluate the inherent value of breast cancer therapy a willingness-to-pay (WTP) study was conducted in Korean patients with metastatic breast cancer. Methods: Patients were prospectively enrolled from four study centers and completed quality of life questionnaires to reflect their status pre-cancer and their current health status. Clinical and socioeconomic data were collected to characterize the population and utilize during modeling. Patients' WTP for breast cancer treatment was assessed using an open-ended question following three rounds of bidding to better hone in on their maximal WTP, starting with one of three randomly assigned start bids. Predictors of patient WTP was evaluated using linear regression models. Associations between WTP and other parameters were evaluated with correlations. Results: Korean metastatic breast cancer patients were WTP an average of KRW 8696329 (US$7555) per month to return to their pre-cancer health state, with those who were recently diagnosed as WTP the most (KRW 12955000 [$11254]). WTP was closely associated with the patient's education level, income, personal financial difficulties, Eastern Cooperative Oncology Group performance status, and their experience of arm symptoms. Conclusion: The results suggest that patients are WTP significant amounts per month for treatment. Breast cancer patients are heavily burdened physically, mentally and financially, and the present study indicated this significant financial burden by disclosing its relationship with WTP. Providing a better understanding of the inherent value of treatment will allow Koreans to better evaluate treatment in the coming era of personalized medicine.

AB - Aims: To evaluate the inherent value of breast cancer therapy a willingness-to-pay (WTP) study was conducted in Korean patients with metastatic breast cancer. Methods: Patients were prospectively enrolled from four study centers and completed quality of life questionnaires to reflect their status pre-cancer and their current health status. Clinical and socioeconomic data were collected to characterize the population and utilize during modeling. Patients' WTP for breast cancer treatment was assessed using an open-ended question following three rounds of bidding to better hone in on their maximal WTP, starting with one of three randomly assigned start bids. Predictors of patient WTP was evaluated using linear regression models. Associations between WTP and other parameters were evaluated with correlations. Results: Korean metastatic breast cancer patients were WTP an average of KRW 8696329 (US$7555) per month to return to their pre-cancer health state, with those who were recently diagnosed as WTP the most (KRW 12955000 [$11254]). WTP was closely associated with the patient's education level, income, personal financial difficulties, Eastern Cooperative Oncology Group performance status, and their experience of arm symptoms. Conclusion: The results suggest that patients are WTP significant amounts per month for treatment. Breast cancer patients are heavily burdened physically, mentally and financially, and the present study indicated this significant financial burden by disclosing its relationship with WTP. Providing a better understanding of the inherent value of treatment will allow Koreans to better evaluate treatment in the coming era of personalized medicine.

UR - http://www.scopus.com/inward/record.url?scp=84865417329&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865417329&partnerID=8YFLogxK

U2 - 10.1111/j.1743-7563.2012.01546.x

DO - 10.1111/j.1743-7563.2012.01546.x

M3 - Article

VL - 8

SP - 282

EP - 291

JO - Asia-Pacific Journal of Clinical Oncology

JF - Asia-Pacific Journal of Clinical Oncology

SN - 1743-7555

IS - 3

ER -